[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian  McDonald", "age": 35, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan E. S. K. Cheung B.Com., CA, CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 89226, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 58, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 181092, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark A. Smith M.D., Ph.D.", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 243539, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & VP of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 39.11, "open": 38.39, "dayLow": 36.8093, "dayHigh": 39.1, "regularMarketPreviousClose": 39.11, "regularMarketOpen": 38.39, "regularMarketDayLow": 36.8093, "regularMarketDayHigh": 39.1, "beta": 1.132, "volume": 51471, "regularMarketVolume": 51471, "averageVolume": 3062801, "averageVolume10days": 90630, "averageDailyVolume10Day": 90630, "bid": 38.04, "ask": 39.23, "bidSize": 100, "askSize": 100, "marketCap": 264544576, "fiftyTwoWeekLow": 0.93, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 39.5345, "twoHundredDayAverage": 10.745055, "currency": "USD", "enterpriseValue": 166351072, "floatShares": 631097, "sharesOutstanding": 6076740, "sharesShort": 221369, "sharesShortPriorMonth": 322606, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0317, "heldPercentInsiders": 0.27283, "heldPercentInstitutions": 0.44279, "shortRatio": 0.7, "shortPercentOfFloat": 0.0363, "impliedSharesOutstanding": 6844620, "bookValue": 1.366, "priceToBook": 28.29429, "lastFiscalYearEnd": 1696032000, "nextFiscalYearEnd": 1727654400, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -3580629, "trailingEps": -0.61, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 25.073334, "SandP52WeekChange": 0.2421279, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "DRUG", "underlyingSymbol": "DRUG", "shortName": "Bright Minds Biosciences Inc.", "longName": "Bright Minds Biosciences Inc.", "firstTradeDateEpochUtc": 1616419800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "7de90f41-6566-3a5c-a990-c3e8fec46e3b", "messageBoardId": "finmb_691048918", "gmtOffSetMilliseconds": -18000000, "currentPrice": 38.65, "recommendationKey": "none", "totalCash": 6190244, "totalCashPerShare": 1.387, "totalDebt": 14016, "quickRatio": 34.751, "currentRatio": 35.077, "debtToEquity": 0.23, "returnOnAssets": -0.28858998, "returnOnEquity": -0.51799, "freeCashflow": -1337075, "operatingCashflow": -2584540, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-12-21"}]